Stocks up as vaccine shields against second-wave worries

* Indexes steady but rotation to beaten-down sectors deepens

* Airline buying moderates; currency markets steady ahead of ECB

* Kiwi touches 19-month high after RBNZ meeting

* Asian stock markets: Link

By Tom Westbrook and Lawrence Delevingne

SYDNEY/BOSTON, Nov 11 (Reuters) - Stock markets gained on Wednesday, as news of a working COVID-19 vaccine seemed to inoculate investors against worry about surging infections in Europe and the United States, while the kiwi rose as traders thought the central bank sounded upbeat.

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS rose 0.4% and Japan's Nikkei .N225 rose 1%, although most of the action was switching between sectors within markets, as investors shift from coronavirus winners into some of the hardest hit sectors.

Banks, for example, made modest additions to Tuesday gains, as did energy and some travel stocks while tech companies fell. Oil futures sat by two-month highs on anticipation of better demand in a post-pandemic world.

Currency markets were mostly steady save for the kiwi, which climbed half a percent to a 19-month high after the Reserve Bank of New Zealand kept rates on hold, as expected, but sounded less dovish than forecast about the outlook.

Other majors and fixed income markets were mostly flat with traders unwilling to extend a selloff in the haven assets of bonds and the yen while a trying northern winter looms.

S&P 500 futures ESc1 wobbled either side of flat and Nasdaq 100 futures NQc1 rose 0.4% after another session of Wall Street selling of hitherto soaring big tech firms.

"A rotation theme remains evident in equity markets," said National Australia Bank strategist Rodrigo Catril in a note.

"Big tech, which has benefited from our virus-driven change in behaviour, is now falling out of favour while small-cap stocks and those that have been most affected by social distancing restrictions have outperformed." Inc AMZN.O was also under pressure overnight after European authorities filed an antitrust suit against the online retailing giant. It has suffered its sharpest two-day drop since March, shedding 8%, though has gained 64% this year.

In Hong Kong on Wednesday the Hang Seng .HSI traded just below flat as gains in financials were outweighed by losses in tech names such as Tencent 0700.HK and Alibaba 9988.HK .

In Tokyo, industrials led the charge as enthusiasm for buying airlines petered out.

In Australia banks .AXFJ made small gains while camping gear retailers, buy-now-pay-later darling Afterpay APT.AX and Dominos Pizza DMP.AX extended losses.


The moves mirror a Wall Street rotation since Pfizer Inc PFE.N announced on Monday that its COVID-19 vaccine candidate, developed with German partner BioNTech BNTX.O , showed a 90% success rate in preventing infection during trials.

The blue-chip Dow Jones .DJI , buoyed by industrial shares, is up nearly 4% this week, while the tech-heavy Nasdaq .IXIC has lost almost that much and the S&P 500 .SPX is up 1%.

That came with a big selloff in U.S. Treasuries and the Japanese yen, even while COVID-19 deaths have crossed 300,000 in Europe and keep rising in spite of a second series of social restrictions as the northern autumn turns to winter.

"The rate of change that we've seen in the U.S. bond market over the last few days is just not sustainable," said Chris Weston, head of research at broker Pepperstone, who is looking for more easing from the U.S. Federal Reserve next month.

"Given the shaky patch that we know we've got to navigate through, which is going to be a very dark winter in the U.S...I just can't see a situation where the Fed don't do something to keep nominal bond yields in check."

Investors are also looking to hear from European Central Bank president Christine Lagarde about the European economic outlook and stimulus prospects in a speech at 1300 GMT.

The U.S. bond market is shut for Veterans Day but the yield on benchmark 10-year Treasuries US10YT=RR posted its highest close since March on Tuesday at 0.9720%.

Brent crude futures LCOc1 were last 30 cents firmer at $43.90 a barrel, just below a two-month high made overnight. Gold XAU= was steady at $1,879.36 an ounce.

Global assets Link
Global currencies vs. dollar Link
Emerging markets Link
MSCI All Country Wolrd Index Market Cap Link

Reporting by Tom Westbrook in Sydney and Lawrence Delevingne
in Boston; Editing by Sam Holmes and Lincoln Feast.

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.